Medical Care
Global Gene Therapy Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
- Mar 24, 25
- ID: 150167
- Pages: 93
- Figures: 91
- Views: 47
The global Gene Therapy market size was US$ 11480 million in 2024 and is forecast to a readjusted size of US$ 61870 million by 2031 with a CAGR of 27.6% during the forecast period 2025-2031.
Gene therapy is an experimental treatment that involves introducing genetic material into a person’s cells to fight or prevent disease. Researchers are studying gene therapy for a number of diseases, such as severe combined immuno-deficiencies, hemophilia, Parkinson"s disease, cancer and even HIV, through a number of different approaches. A gene can be delivered to a cell using a carrier known as a “vector.” The most common types of vectors used in gene therapy are viruses. The viruses used in gene therapy are altered to make them safe, although some risks still exist with gene therapy. The technology is still in its infancy.
Global Gene Therapy key players include Biogen, Novartis, Gilead Sciences, etc. Global top three manufacturers hold a share about 75%.
North America is the largest market, with a share about 60%, followed by Europe and Asia-Pacific, both have a share about 35 percent.
In terms of product, Non-viral Gene Therapy is the largest segment, with a share about 55%. And in terms of application, the largest application is Neurological Diseases, followed by Cancer.
The global Gene Therapy market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on revenue and forecasts across regions, by Type, and by Application for 2020-2031.
Market Segmentation
By Company:
Biogen
Novartis
Gilead Sciences
Sarepta Therapeutics
Alnylam Pharmaceuticals
Amgen
Spark Therapeutics
Akcea Therapeutics
bluebird bio
Sunway Biotech
SIBIONO
AnGes
Orchard Therapeutics
Human Stem Cells Institute
By Type: (Dominant Segment vs High-Margin Innovation)
Viral Gene Therapy
Non-Viral Gene Therapy
By Application: (Core Demand Driver vs Emerging Opportunity)
Neurological Diseases
Cancer
Other
By Region
Macro-Regional Analysis: Market Size & Growth Forecasts
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Micro-Local Market Deep Dive: Strategic Insights
- Competitive Landscape: Player dominance vs. disruptors (e.g., Biogen in Europe)
- Emerging Product Trends: Viral Gene Therapy adoption vs. Non-Viral Gene Therapy premiumization
- Demand-Side Dynamics: Neurological Diseases growth in China vs. Cancer potential in North America
- Localized Consumer Needs: Regulatory hurdles in EU vs. price sensitivity in India
Focus Markets:
North America
Europe
China
Japan
Southeast Asia
India
Middle East And Africa
Chapter Outline
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Gene Therapy market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Non-Viral Gene Therapy in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Cancer in India).
Chapter 6: Regional revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Gene Therapy value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets
Gene therapy is an experimental treatment that involves introducing genetic material into a person’s cells to fight or prevent disease. Researchers are studying gene therapy for a number of diseases, such as severe combined immuno-deficiencies, hemophilia, Parkinson"s disease, cancer and even HIV, through a number of different approaches. A gene can be delivered to a cell using a carrier known as a “vector.” The most common types of vectors used in gene therapy are viruses. The viruses used in gene therapy are altered to make them safe, although some risks still exist with gene therapy. The technology is still in its infancy.
Global Gene Therapy key players include Biogen, Novartis, Gilead Sciences, etc. Global top three manufacturers hold a share about 75%.
North America is the largest market, with a share about 60%, followed by Europe and Asia-Pacific, both have a share about 35 percent.
In terms of product, Non-viral Gene Therapy is the largest segment, with a share about 55%. And in terms of application, the largest application is Neurological Diseases, followed by Cancer.
The global Gene Therapy market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on revenue and forecasts across regions, by Type, and by Application for 2020-2031.
Market Segmentation
By Company:
Biogen
Novartis
Gilead Sciences
Sarepta Therapeutics
Alnylam Pharmaceuticals
Amgen
Spark Therapeutics
Akcea Therapeutics
bluebird bio
Sunway Biotech
SIBIONO
AnGes
Orchard Therapeutics
Human Stem Cells Institute
By Type: (Dominant Segment vs High-Margin Innovation)
Viral Gene Therapy
Non-Viral Gene Therapy
By Application: (Core Demand Driver vs Emerging Opportunity)
Neurological Diseases
Cancer
Other
By Region
Macro-Regional Analysis: Market Size & Growth Forecasts
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Micro-Local Market Deep Dive: Strategic Insights
- Competitive Landscape: Player dominance vs. disruptors (e.g., Biogen in Europe)
- Emerging Product Trends: Viral Gene Therapy adoption vs. Non-Viral Gene Therapy premiumization
- Demand-Side Dynamics: Neurological Diseases growth in China vs. Cancer potential in North America
- Localized Consumer Needs: Regulatory hurdles in EU vs. price sensitivity in India
Focus Markets:
North America
Europe
China
Japan
Southeast Asia
India
Middle East And Africa
Chapter Outline
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Gene Therapy market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Non-Viral Gene Therapy in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Cancer in India).
Chapter 6: Regional revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Gene Therapy value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets
1 Report Overview
1.1 Study Scope
1.2 Market by Type
1.2.1 Global Market Size Growth by Type: 2020 VS 2024 VS 2031
1.2.2 Viral Gene Therapy
1.2.3 Non-Viral Gene Therapy
1.3 Market by Application
1.3.1 Global Market Share by Application: 2020 VS 2024 VS 2031
1.3.2 Neurological Diseases
1.3.3 Cancer
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Gene Therapy Market Perspective (2020-2031)
2.2 Global Market Size by Region: 2020 VS 2024 VS 2031
2.3 Global Gene Therapy Revenue Market Share by Region (2020-2025)
2.4 Global Gene Therapy Revenue Forecast by Region (2026-2031)
2.5 Major Region and Emerging Market Analysis
2.5.1 North America Gene Therapy Market Size and Prospective (2020-2031)
2.5.2 Europe Gene Therapy Market Size and Prospective (2020-2031)
2.5.3 China Gene Therapy Market Size and Prospective (2020-2031)
2.5.4 Japan Gene Therapy Market Size and Prospective (2020-2031)
2.5.5 Southeast Asia Gene Therapy Market Size and Prospective (2020-2031)
2.5.6 India Gene Therapy Market Size and Prospective (2020-2031)
2.5.7 Middle East And Africa Gene Therapy Market Size and Prospective (2020-2031)
3 Breakdown Data by Type
3.1 Global Gene Therapy Historic Market Size by Type (2020-2025)
3.2 Global Gene Therapy Forecasted Market Size by Type (2026-2031)
3.3 Different Types Gene Therapy Representative Players
4 Breakdown Data by Application
4.1 Global Gene Therapy Historic Market Size by Application (2020-2025)
4.2 Global Gene Therapy Forecasted Market Size by Application (2026-2031)
4.3 New Sources of Growth in Gene Therapy Application
5 Competition Landscape by Players
5.1 Global Top Players by Revenue
5.1.1 Global Top Gene Therapy Players by Revenue (2020-2025)
5.1.2 Global Gene Therapy Revenue Market Share by Players (2020-2025)
5.2 Global Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
5.3 Players Covered: Ranking by Gene Therapy Revenue
5.4 Global Gene Therapy Market Concentration Analysis
5.4.1 Global Gene Therapy Market Concentration Ratio (CR5 and HHI)
5.4.2 Global Top 10 and Top 5 Companies by Gene Therapy Revenue in 2024
5.5 Global Key Players of Gene Therapy Head office and Area Served
5.6 Global Key Players of Gene Therapy, Product and Application
5.7 Global Key Players of Gene Therapy, Date of Enter into This Industry
5.8 Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments and Downstream
6.1.1 North America Gene Therapy Revenue by Company (2020-2025)
6.1.2 North America Market Size by Type
6.1.2.1 North America Gene Therapy Market Size by Type (2020-2025)
6.1.2.2 North America Gene Therapy Market Share by Type (2020-2025)
6.1.3 North America Market Size by Application
6.1.3.1 North America Gene Therapy Market Size by Application (2020-2025)
6.1.3.2 North America Gene Therapy Market Share by Application (2020-2025)
6.1.4 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments and Downstream
6.2.1 Europe Gene Therapy Revenue by Company (2020-2025)
6.2.2 Europe Market Size by Type
6.2.2.1 Europe Gene Therapy Market Size by Type (2020-2025)
6.2.2.2 Europe Gene Therapy Market Share by Type (2020-2025)
6.2.3 Europe Market Size by Application
6.2.3.1 Europe Gene Therapy Market Size by Application (2020-2025)
6.2.3.2 Europe Gene Therapy Market Share by Application (2020-2025)
6.2.4 Europe Market Trend and Opportunities
6.3 China Market: Players, Segments and Downstream
6.3.1 China Gene Therapy Revenue by Company (2020-2025)
6.3.2 China Market Size by Type
6.3.2.1 China Gene Therapy Market Size by Type (2020-2025)
6.3.2.2 China Gene Therapy Market Share by Type (2020-2025)
6.3.3 China Market Size by Application
6.3.3.1 China Gene Therapy Market Size by Application (2020-2025)
6.3.3.2 China Gene Therapy Market Share by Application (2020-2025)
6.3.4 China Market Trend and Opportunities
6.4 Japan Market: Players, Segments and Downstream
6.4.1 Japan Gene Therapy Revenue by Company (2020-2025)
6.4.2 Japan Market Size by Type
6.4.2.1 Japan Gene Therapy Market Size by Type (2020-2025)
6.4.2.2 Japan Gene Therapy Market Share by Type (2020-2025)
6.4.3 Japan Market Size by Application
6.4.3.1 Japan Gene Therapy Market Size by Application (2020-2025)
6.4.3.2 Japan Gene Therapy Market Share by Application (2020-2025)
6.4.4 Japan Market Trend and Opportunities
6.5 Southeast Asia Market: Players, Segments and Downstream
6.5.1 Southeast Asia Gene Therapy Revenue by Company (2020-2025)
6.5.2 Southeast Asia Market Size by Type
6.5.2.1 Southeast Asia Gene Therapy Market Size by Type (2020-2025)
6.5.2.2 Southeast Asia Gene Therapy Market Share by Type (2020-2025)
6.5.3 Southeast Asia Market Size by Application
6.5.3.1 Southeast Asia Gene Therapy Market Size by Application (2020-2025)
6.5.3.2 Southeast Asia Gene Therapy Market Share by Application (2020-2025)
6.5.4 Southeast Asia Market Trend and Opportunities
6.6 India Market: Players, Segments and Downstream
6.6.1 India Gene Therapy Revenue by Company (2020-2025)
6.6.2 India Market Size by Type
6.6.2.1 India Gene Therapy Market Size by Type (2020-2025)
6.6.2.2 India Gene Therapy Market Share by Type (2020-2025)
6.6.3 India Market Size by Application
6.6.3.1 India Gene Therapy Market Size by Application (2020-2025)
6.6.3.2 India Gene Therapy Market Share by Application (2020-2025)
6.6.4 India Market Trend and Opportunities
7 Key Players Profiles
7.1 Biogen
7.1.1 Biogen Company Details
7.1.2 Biogen Business Overview
7.1.3 Biogen Gene Therapy Introduction
7.1.4 Biogen Revenue in Gene Therapy Business (2020-2025)
7.1.5 Biogen Recent Development
7.2 Novartis
7.2.1 Novartis Company Details
7.2.2 Novartis Business Overview
7.2.3 Novartis Gene Therapy Introduction
7.2.4 Novartis Revenue in Gene Therapy Business (2020-2025)
7.2.5 Novartis Recent Development
7.3 Gilead Sciences
7.3.1 Gilead Sciences Company Details
7.3.2 Gilead Sciences Business Overview
7.3.3 Gilead Sciences Gene Therapy Introduction
7.3.4 Gilead Sciences Revenue in Gene Therapy Business (2020-2025)
7.3.5 Gilead Sciences Recent Development
7.4 Sarepta Therapeutics
7.4.1 Sarepta Therapeutics Company Details
7.4.2 Sarepta Therapeutics Business Overview
7.4.3 Sarepta Therapeutics Gene Therapy Introduction
7.4.4 Sarepta Therapeutics Revenue in Gene Therapy Business (2020-2025)
7.4.5 Sarepta Therapeutics Recent Development
7.5 Alnylam Pharmaceuticals
7.5.1 Alnylam Pharmaceuticals Company Details
7.5.2 Alnylam Pharmaceuticals Business Overview
7.5.3 Alnylam Pharmaceuticals Gene Therapy Introduction
7.5.4 Alnylam Pharmaceuticals Revenue in Gene Therapy Business (2020-2025)
7.5.5 Alnylam Pharmaceuticals Recent Development
7.6 Amgen
7.6.1 Amgen Company Details
7.6.2 Amgen Business Overview
7.6.3 Amgen Gene Therapy Introduction
7.6.4 Amgen Revenue in Gene Therapy Business (2020-2025)
7.6.5 Amgen Recent Development
7.7 Spark Therapeutics
7.7.1 Spark Therapeutics Company Details
7.7.2 Spark Therapeutics Business Overview
7.7.3 Spark Therapeutics Gene Therapy Introduction
7.7.4 Spark Therapeutics Revenue in Gene Therapy Business (2020-2025)
7.7.5 Spark Therapeutics Recent Development
7.8 Akcea Therapeutics
7.8.1 Akcea Therapeutics Company Details
7.8.2 Akcea Therapeutics Business Overview
7.8.3 Akcea Therapeutics Gene Therapy Introduction
7.8.4 Akcea Therapeutics Revenue in Gene Therapy Business (2020-2025)
7.8.5 Akcea Therapeutics Recent Development
7.9 bluebird bio
7.9.1 bluebird bio Company Details
7.9.2 bluebird bio Business Overview
7.9.3 bluebird bio Gene Therapy Introduction
7.9.4 bluebird bio Revenue in Gene Therapy Business (2020-2025)
7.9.5 bluebird bio Recent Development
7.10 Sunway Biotech
7.10.1 Sunway Biotech Company Details
7.10.2 Sunway Biotech Business Overview
7.10.3 Sunway Biotech Gene Therapy Introduction
7.10.4 Sunway Biotech Revenue in Gene Therapy Business (2020-2025)
7.10.5 Sunway Biotech Recent Development
7.11 SIBIONO
7.11.1 SIBIONO Company Details
7.11.2 SIBIONO Business Overview
7.11.3 SIBIONO Gene Therapy Introduction
7.11.4 SIBIONO Revenue in Gene Therapy Business (2020-2025)
7.11.5 SIBIONO Recent Development
7.12 AnGes
7.12.1 AnGes Company Details
7.12.2 AnGes Business Overview
7.12.3 AnGes Gene Therapy Introduction
7.12.4 AnGes Revenue in Gene Therapy Business (2020-2025)
7.12.5 AnGes Recent Development
7.13 Orchard Therapeutics
7.13.1 Orchard Therapeutics Company Details
7.13.2 Orchard Therapeutics Business Overview
7.13.3 Orchard Therapeutics Gene Therapy Introduction
7.13.4 Orchard Therapeutics Revenue in Gene Therapy Business (2020-2025)
7.13.5 Orchard Therapeutics Recent Development
7.14 Human Stem Cells Institute
7.14.1 Human Stem Cells Institute Company Details
7.14.2 Human Stem Cells Institute Business Overview
7.14.3 Human Stem Cells Institute Gene Therapy Introduction
7.14.4 Human Stem Cells Institute Revenue in Gene Therapy Business (2020-2025)
7.14.5 Human Stem Cells Institute Recent Development
8 Gene Therapy Market Dynamics
8.1 Gene Therapy Industry Trends
8.2 Gene Therapy Market Drivers
8.3 Gene Therapy Market Challenges
8.4 Gene Therapy Market Restraints
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
1.1 Study Scope
1.2 Market by Type
1.2.1 Global Market Size Growth by Type: 2020 VS 2024 VS 2031
1.2.2 Viral Gene Therapy
1.2.3 Non-Viral Gene Therapy
1.3 Market by Application
1.3.1 Global Market Share by Application: 2020 VS 2024 VS 2031
1.3.2 Neurological Diseases
1.3.3 Cancer
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Gene Therapy Market Perspective (2020-2031)
2.2 Global Market Size by Region: 2020 VS 2024 VS 2031
2.3 Global Gene Therapy Revenue Market Share by Region (2020-2025)
2.4 Global Gene Therapy Revenue Forecast by Region (2026-2031)
2.5 Major Region and Emerging Market Analysis
2.5.1 North America Gene Therapy Market Size and Prospective (2020-2031)
2.5.2 Europe Gene Therapy Market Size and Prospective (2020-2031)
2.5.3 China Gene Therapy Market Size and Prospective (2020-2031)
2.5.4 Japan Gene Therapy Market Size and Prospective (2020-2031)
2.5.5 Southeast Asia Gene Therapy Market Size and Prospective (2020-2031)
2.5.6 India Gene Therapy Market Size and Prospective (2020-2031)
2.5.7 Middle East And Africa Gene Therapy Market Size and Prospective (2020-2031)
3 Breakdown Data by Type
3.1 Global Gene Therapy Historic Market Size by Type (2020-2025)
3.2 Global Gene Therapy Forecasted Market Size by Type (2026-2031)
3.3 Different Types Gene Therapy Representative Players
4 Breakdown Data by Application
4.1 Global Gene Therapy Historic Market Size by Application (2020-2025)
4.2 Global Gene Therapy Forecasted Market Size by Application (2026-2031)
4.3 New Sources of Growth in Gene Therapy Application
5 Competition Landscape by Players
5.1 Global Top Players by Revenue
5.1.1 Global Top Gene Therapy Players by Revenue (2020-2025)
5.1.2 Global Gene Therapy Revenue Market Share by Players (2020-2025)
5.2 Global Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
5.3 Players Covered: Ranking by Gene Therapy Revenue
5.4 Global Gene Therapy Market Concentration Analysis
5.4.1 Global Gene Therapy Market Concentration Ratio (CR5 and HHI)
5.4.2 Global Top 10 and Top 5 Companies by Gene Therapy Revenue in 2024
5.5 Global Key Players of Gene Therapy Head office and Area Served
5.6 Global Key Players of Gene Therapy, Product and Application
5.7 Global Key Players of Gene Therapy, Date of Enter into This Industry
5.8 Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments and Downstream
6.1.1 North America Gene Therapy Revenue by Company (2020-2025)
6.1.2 North America Market Size by Type
6.1.2.1 North America Gene Therapy Market Size by Type (2020-2025)
6.1.2.2 North America Gene Therapy Market Share by Type (2020-2025)
6.1.3 North America Market Size by Application
6.1.3.1 North America Gene Therapy Market Size by Application (2020-2025)
6.1.3.2 North America Gene Therapy Market Share by Application (2020-2025)
6.1.4 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments and Downstream
6.2.1 Europe Gene Therapy Revenue by Company (2020-2025)
6.2.2 Europe Market Size by Type
6.2.2.1 Europe Gene Therapy Market Size by Type (2020-2025)
6.2.2.2 Europe Gene Therapy Market Share by Type (2020-2025)
6.2.3 Europe Market Size by Application
6.2.3.1 Europe Gene Therapy Market Size by Application (2020-2025)
6.2.3.2 Europe Gene Therapy Market Share by Application (2020-2025)
6.2.4 Europe Market Trend and Opportunities
6.3 China Market: Players, Segments and Downstream
6.3.1 China Gene Therapy Revenue by Company (2020-2025)
6.3.2 China Market Size by Type
6.3.2.1 China Gene Therapy Market Size by Type (2020-2025)
6.3.2.2 China Gene Therapy Market Share by Type (2020-2025)
6.3.3 China Market Size by Application
6.3.3.1 China Gene Therapy Market Size by Application (2020-2025)
6.3.3.2 China Gene Therapy Market Share by Application (2020-2025)
6.3.4 China Market Trend and Opportunities
6.4 Japan Market: Players, Segments and Downstream
6.4.1 Japan Gene Therapy Revenue by Company (2020-2025)
6.4.2 Japan Market Size by Type
6.4.2.1 Japan Gene Therapy Market Size by Type (2020-2025)
6.4.2.2 Japan Gene Therapy Market Share by Type (2020-2025)
6.4.3 Japan Market Size by Application
6.4.3.1 Japan Gene Therapy Market Size by Application (2020-2025)
6.4.3.2 Japan Gene Therapy Market Share by Application (2020-2025)
6.4.4 Japan Market Trend and Opportunities
6.5 Southeast Asia Market: Players, Segments and Downstream
6.5.1 Southeast Asia Gene Therapy Revenue by Company (2020-2025)
6.5.2 Southeast Asia Market Size by Type
6.5.2.1 Southeast Asia Gene Therapy Market Size by Type (2020-2025)
6.5.2.2 Southeast Asia Gene Therapy Market Share by Type (2020-2025)
6.5.3 Southeast Asia Market Size by Application
6.5.3.1 Southeast Asia Gene Therapy Market Size by Application (2020-2025)
6.5.3.2 Southeast Asia Gene Therapy Market Share by Application (2020-2025)
6.5.4 Southeast Asia Market Trend and Opportunities
6.6 India Market: Players, Segments and Downstream
6.6.1 India Gene Therapy Revenue by Company (2020-2025)
6.6.2 India Market Size by Type
6.6.2.1 India Gene Therapy Market Size by Type (2020-2025)
6.6.2.2 India Gene Therapy Market Share by Type (2020-2025)
6.6.3 India Market Size by Application
6.6.3.1 India Gene Therapy Market Size by Application (2020-2025)
6.6.3.2 India Gene Therapy Market Share by Application (2020-2025)
6.6.4 India Market Trend and Opportunities
7 Key Players Profiles
7.1 Biogen
7.1.1 Biogen Company Details
7.1.2 Biogen Business Overview
7.1.3 Biogen Gene Therapy Introduction
7.1.4 Biogen Revenue in Gene Therapy Business (2020-2025)
7.1.5 Biogen Recent Development
7.2 Novartis
7.2.1 Novartis Company Details
7.2.2 Novartis Business Overview
7.2.3 Novartis Gene Therapy Introduction
7.2.4 Novartis Revenue in Gene Therapy Business (2020-2025)
7.2.5 Novartis Recent Development
7.3 Gilead Sciences
7.3.1 Gilead Sciences Company Details
7.3.2 Gilead Sciences Business Overview
7.3.3 Gilead Sciences Gene Therapy Introduction
7.3.4 Gilead Sciences Revenue in Gene Therapy Business (2020-2025)
7.3.5 Gilead Sciences Recent Development
7.4 Sarepta Therapeutics
7.4.1 Sarepta Therapeutics Company Details
7.4.2 Sarepta Therapeutics Business Overview
7.4.3 Sarepta Therapeutics Gene Therapy Introduction
7.4.4 Sarepta Therapeutics Revenue in Gene Therapy Business (2020-2025)
7.4.5 Sarepta Therapeutics Recent Development
7.5 Alnylam Pharmaceuticals
7.5.1 Alnylam Pharmaceuticals Company Details
7.5.2 Alnylam Pharmaceuticals Business Overview
7.5.3 Alnylam Pharmaceuticals Gene Therapy Introduction
7.5.4 Alnylam Pharmaceuticals Revenue in Gene Therapy Business (2020-2025)
7.5.5 Alnylam Pharmaceuticals Recent Development
7.6 Amgen
7.6.1 Amgen Company Details
7.6.2 Amgen Business Overview
7.6.3 Amgen Gene Therapy Introduction
7.6.4 Amgen Revenue in Gene Therapy Business (2020-2025)
7.6.5 Amgen Recent Development
7.7 Spark Therapeutics
7.7.1 Spark Therapeutics Company Details
7.7.2 Spark Therapeutics Business Overview
7.7.3 Spark Therapeutics Gene Therapy Introduction
7.7.4 Spark Therapeutics Revenue in Gene Therapy Business (2020-2025)
7.7.5 Spark Therapeutics Recent Development
7.8 Akcea Therapeutics
7.8.1 Akcea Therapeutics Company Details
7.8.2 Akcea Therapeutics Business Overview
7.8.3 Akcea Therapeutics Gene Therapy Introduction
7.8.4 Akcea Therapeutics Revenue in Gene Therapy Business (2020-2025)
7.8.5 Akcea Therapeutics Recent Development
7.9 bluebird bio
7.9.1 bluebird bio Company Details
7.9.2 bluebird bio Business Overview
7.9.3 bluebird bio Gene Therapy Introduction
7.9.4 bluebird bio Revenue in Gene Therapy Business (2020-2025)
7.9.5 bluebird bio Recent Development
7.10 Sunway Biotech
7.10.1 Sunway Biotech Company Details
7.10.2 Sunway Biotech Business Overview
7.10.3 Sunway Biotech Gene Therapy Introduction
7.10.4 Sunway Biotech Revenue in Gene Therapy Business (2020-2025)
7.10.5 Sunway Biotech Recent Development
7.11 SIBIONO
7.11.1 SIBIONO Company Details
7.11.2 SIBIONO Business Overview
7.11.3 SIBIONO Gene Therapy Introduction
7.11.4 SIBIONO Revenue in Gene Therapy Business (2020-2025)
7.11.5 SIBIONO Recent Development
7.12 AnGes
7.12.1 AnGes Company Details
7.12.2 AnGes Business Overview
7.12.3 AnGes Gene Therapy Introduction
7.12.4 AnGes Revenue in Gene Therapy Business (2020-2025)
7.12.5 AnGes Recent Development
7.13 Orchard Therapeutics
7.13.1 Orchard Therapeutics Company Details
7.13.2 Orchard Therapeutics Business Overview
7.13.3 Orchard Therapeutics Gene Therapy Introduction
7.13.4 Orchard Therapeutics Revenue in Gene Therapy Business (2020-2025)
7.13.5 Orchard Therapeutics Recent Development
7.14 Human Stem Cells Institute
7.14.1 Human Stem Cells Institute Company Details
7.14.2 Human Stem Cells Institute Business Overview
7.14.3 Human Stem Cells Institute Gene Therapy Introduction
7.14.4 Human Stem Cells Institute Revenue in Gene Therapy Business (2020-2025)
7.14.5 Human Stem Cells Institute Recent Development
8 Gene Therapy Market Dynamics
8.1 Gene Therapy Industry Trends
8.2 Gene Therapy Market Drivers
8.3 Gene Therapy Market Challenges
8.4 Gene Therapy Market Restraints
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Global Gene Therapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Gene Therapy Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Market Gene Therapy Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Table 4. Global Gene Therapy Revenue (US$ Million) Market Share by Region (2020-2025)
Table 5. Global Gene Therapy Revenue Share by Region (2020-2025)
Table 6. Global Gene Therapy Revenue (US$ Million) Forecast by Region (2026-2031)
Table 7. Global Gene Therapy Revenue Share Forecast by Region (2026-2031)
Table 8. Global Gene Therapy Market Size by Type (2020-2025) & (US$ Million)
Table 9. Global Gene Therapy Revenue Market Share by Type (2020-2025)
Table 10. Global Gene Therapy Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 11. Global Gene Therapy Revenue Market Share by Type (2026-2031)
Table 12. Representative Players of Each Type
Table 13. Global Gene Therapy Market Size by Application (2020-2025) & (US$ Million)
Table 14. Global Gene Therapy Revenue Market Share by Application (2020-2025)
Table 15. Global Gene Therapy Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 16. Global Gene Therapy Revenue Market Share by Application (2026-2031)
Table 17. New Sources of Growth in Gene Therapy Application
Table 18. Global Gene Therapy Revenue by Players (2020-2025) & (US$ Million)
Table 19. Global Gene Therapy Market Share by Players (2020-2025)
Table 20. Global Top Gene Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Therapy as of 2024)
Table 21. Ranking of Global Top Gene Therapy Companies by Revenue (US$ Million) in 2024
Table 22. Global 5 Largest Players Market Share by Gene Therapy Revenue (CR5 and HHI) & (2020-2025)
Table 23. Global Key Players of Gene Therapy, Headquarters and Area Served
Table 24. Global Key Players of Gene Therapy, Product and Application
Table 25. Global Key Players of Gene Therapy, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. North America Gene Therapy Revenue by Company (2020-2025) & (US$ Million)
Table 28. North America Gene Therapy Revenue Market Share by Company (2020-2025)
Table 29. North America Gene Therapy Market Size by Type (2020-2025) & (US$ Million)
Table 30. North America Gene Therapy Market Size by Application (2020-2025) & (US$ Million)
Table 31. Europe Gene Therapy Revenue by Company (2020-2025) & (US$ Million)
Table 32. Europe Gene Therapy Revenue Market Share by Company (2020-2025)
Table 33. Europe Gene Therapy Market Size by Type (2020-2025) & (US$ Million)
Table 34. Europe Gene Therapy Market Size by Application (2020-2025) & (US$ Million)
Table 35. China Gene Therapy Revenue by Company (2020-2025) & (US$ Million)
Table 36. China Gene Therapy Revenue Market Share by Company (2020-2025)
Table 37. China Gene Therapy Market Size by Type (2020-2025) & (US$ Million)
Table 38. China Gene Therapy Market Size by Application (2020-2025) & (US$ Million)
Table 39. Japan Gene Therapy Revenue by Company (2020-2025) & (US$ Million)
Table 40. Japan Gene Therapy Revenue Market Share by Company (2020-2025)
Table 41. Japan Gene Therapy Market Size by Type (2020-2025) & (US$ Million)
Table 42. Japan Gene Therapy Market Size by Application (2020-2025) & (US$ Million)
Table 43. Southeast Asia Gene Therapy Revenue by Company (2020-2025) & (US$ Million)
Table 44. Southeast Asia Gene Therapy Revenue Market Share by Company (2020-2025)
Table 45. Southeast Asia Gene Therapy Market Size by Type (2020-2025) & (US$ Million)
Table 46. Southeast Asia Gene Therapy Market Size by Application (2020-2025) & (US$ Million)
Table 47. India Gene Therapy Revenue by Company (2020-2025) & (US$ Million)
Table 48. India Gene Therapy Revenue Market Share by Company (2020-2025)
Table 49. India Gene Therapy Market Size by Type (2020-2025) & (US$ Million)
Table 50. India Gene Therapy Market Size by Application (2020-2025) & (US$ Million)
Table 51. Biogen Company Details
Table 52. Biogen Business Overview
Table 53. Biogen Gene Therapy Product
Table 54. Biogen Revenue in Gene Therapy Business (2020-2025) & (US$ Million)
Table 55. Biogen Recent Development
Table 56. Novartis Company Details
Table 57. Novartis Business Overview
Table 58. Novartis Gene Therapy Product
Table 59. Novartis Revenue in Gene Therapy Business (2020-2025) & (US$ Million)
Table 60. Novartis Recent Development
Table 61. Gilead Sciences Company Details
Table 62. Gilead Sciences Business Overview
Table 63. Gilead Sciences Gene Therapy Product
Table 64. Gilead Sciences Revenue in Gene Therapy Business (2020-2025) & (US$ Million)
Table 65. Gilead Sciences Recent Development
Table 66. Sarepta Therapeutics Company Details
Table 67. Sarepta Therapeutics Business Overview
Table 68. Sarepta Therapeutics Gene Therapy Product
Table 69. Sarepta Therapeutics Revenue in Gene Therapy Business (2020-2025) & (US$ Million)
Table 70. Sarepta Therapeutics Recent Development
Table 71. Alnylam Pharmaceuticals Company Details
Table 72. Alnylam Pharmaceuticals Business Overview
Table 73. Alnylam Pharmaceuticals Gene Therapy Product
Table 74. Alnylam Pharmaceuticals Revenue in Gene Therapy Business (2020-2025) & (US$ Million)
Table 75. Alnylam Pharmaceuticals Recent Development
Table 76. Amgen Company Details
Table 77. Amgen Business Overview
Table 78. Amgen Gene Therapy Product
Table 79. Amgen Revenue in Gene Therapy Business (2020-2025) & (US$ Million)
Table 80. Amgen Recent Development
Table 81. Spark Therapeutics Company Details
Table 82. Spark Therapeutics Business Overview
Table 83. Spark Therapeutics Gene Therapy Product
Table 84. Spark Therapeutics Revenue in Gene Therapy Business (2020-2025) & (US$ Million)
Table 85. Spark Therapeutics Recent Development
Table 86. Akcea Therapeutics Company Details
Table 87. Akcea Therapeutics Business Overview
Table 88. Akcea Therapeutics Gene Therapy Product
Table 89. Akcea Therapeutics Revenue in Gene Therapy Business (2020-2025) & (US$ Million)
Table 90. Akcea Therapeutics Recent Development
Table 91. bluebird bio Company Details
Table 92. bluebird bio Business Overview
Table 93. bluebird bio Gene Therapy Product
Table 94. bluebird bio Revenue in Gene Therapy Business (2020-2025) & (US$ Million)
Table 95. bluebird bio Recent Development
Table 96. Sunway Biotech Company Details
Table 97. Sunway Biotech Business Overview
Table 98. Sunway Biotech Gene Therapy Product
Table 99. Sunway Biotech Revenue in Gene Therapy Business (2020-2025) & (US$ Million)
Table 100. Sunway Biotech Recent Development
Table 101. SIBIONO Company Details
Table 102. SIBIONO Business Overview
Table 103. SIBIONO Gene Therapy Product
Table 104. SIBIONO Revenue in Gene Therapy Business (2020-2025) & (US$ Million)
Table 105. SIBIONO Recent Development
Table 106. AnGes Company Details
Table 107. AnGes Business Overview
Table 108. AnGes Gene Therapy Product
Table 109. AnGes Revenue in Gene Therapy Business (2020-2025) & (US$ Million)
Table 110. AnGes Recent Development
Table 111. Orchard Therapeutics Company Details
Table 112. Orchard Therapeutics Business Overview
Table 113. Orchard Therapeutics Gene Therapy Product
Table 114. Orchard Therapeutics Revenue in Gene Therapy Business (2020-2025) & (US$ Million)
Table 115. Orchard Therapeutics Recent Development
Table 116. Human Stem Cells Institute Company Details
Table 117. Human Stem Cells Institute Business Overview
Table 118. Human Stem Cells Institute Gene Therapy Product
Table 119. Human Stem Cells Institute Revenue in Gene Therapy Business (2020-2025) & (US$ Million)
Table 120. Human Stem Cells Institute Recent Development
Table 121. Gene Therapy Market Trends
Table 122. Gene Therapy Market Drivers
Table 123. Gene Therapy Market Challenges
Table 124. Gene Therapy Market Restraints
Table 125. Research Programs/Design for This Report
Table 126. Key Data Information from Secondary Sources
Table 127. Key Data Information from Primary Sources
List of Figures
Figure 1. Gene Therapy Product Picture
Figure 2. Global Gene Therapy Market Share by Type: 2024 VS 2031
Figure 3. Viral Gene Therapy Features
Figure 4. Non-Viral Gene Therapy Features
Figure 5. Global Gene Therapy Market Share by Application: 2024 VS 2031
Figure 6. Neurological Diseases
Figure 7. Cancer
Figure 8. Other
Figure 9. Gene Therapy Report Years Considered
Figure 10. Global Gene Therapy Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 11. Global Gene Therapy Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Gene Therapy Revenue Market Share by Region: 2020 VS 2024
Figure 13. North America Gene Therapy Revenue (US$ Million) Growth Rate (2020-2031)
Figure 14. Europe Gene Therapy Revenue (US$ Million) Growth Rate (2020-2031)
Figure 15. China Gene Therapy Revenue (US$ Million) Growth Rate (2020-2031)
Figure 16. Japan Gene Therapy Revenue (US$ Million) Growth Rate (2020-2031)
Figure 17. Southeast Asia Gene Therapy Revenue (US$ Million) Growth Rate (2020-2031)
Figure 18. India Gene Therapy Revenue (US$ Million) Growth Rate (2020-2031)
Figure 19. Middle East And Africa Gene Therapy Revenue (US$ Million) Growth Rate (2020-2031)
Figure 20. Global Gene Therapy Market Share by Players in 2024
Figure 21. Global Top Gene Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Therapy as of 2024)
Figure 22. The Top 10 and 5 Players Market Share by Gene Therapy Revenue in 2024
Figure 23. North America Gene Therapy Market Share by Type (2020-2025)
Figure 24. North America Gene Therapy Market Share by Application (2020-2025)
Figure 25. Europe Gene Therapy Market Share by Type (2020-2025)
Figure 26. Europe Gene Therapy Market Share by Application (2020-2025)
Figure 27. China Gene Therapy Market Share by Type (2020-2025)
Figure 28. China Gene Therapy Market Share by Application (2020-2025)
Figure 29. Japan Gene Therapy Market Share by Type (2020-2025)
Figure 30. Japan Gene Therapy Market Share by Application (2020-2025)
Figure 31. Southeast Asia Gene Therapy Market Share by Type (2020-2025)
Figure 32. Southeast Asia Gene Therapy Market Share by Application (2020-2025)
Figure 33. India Gene Therapy Market Share by Type (2020-2025)
Figure 34. India Gene Therapy Market Share by Application (2020-2025)
Figure 35. Biogen Revenue Growth Rate in Gene Therapy Business (2020-2025)
Figure 36. Novartis Revenue Growth Rate in Gene Therapy Business (2020-2025)
Figure 37. Gilead Sciences Revenue Growth Rate in Gene Therapy Business (2020-2025)
Figure 38. Sarepta Therapeutics Revenue Growth Rate in Gene Therapy Business (2020-2025)
Figure 39. Alnylam Pharmaceuticals Revenue Growth Rate in Gene Therapy Business (2020-2025)
Figure 40. Amgen Revenue Growth Rate in Gene Therapy Business (2020-2025)
Figure 41. Spark Therapeutics Revenue Growth Rate in Gene Therapy Business (2020-2025)
Figure 42. Akcea Therapeutics Revenue Growth Rate in Gene Therapy Business (2020-2025)
Figure 43. bluebird bio Revenue Growth Rate in Gene Therapy Business (2020-2025)
Figure 44. Sunway Biotech Revenue Growth Rate in Gene Therapy Business (2020-2025)
Figure 45. SIBIONO Revenue Growth Rate in Gene Therapy Business (2020-2025)
Figure 46. AnGes Revenue Growth Rate in Gene Therapy Business (2020-2025)
Figure 47. Orchard Therapeutics Revenue Growth Rate in Gene Therapy Business (2020-2025)
Figure 48. Human Stem Cells Institute Revenue Growth Rate in Gene Therapy Business (2020-2025)
Figure 49. Bottom-up and Top-down Approaches for This Report
Figure 50. Data Triangulation
Figure 51. Key Executives Interviewed
Table 1. Global Gene Therapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Gene Therapy Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Market Gene Therapy Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Table 4. Global Gene Therapy Revenue (US$ Million) Market Share by Region (2020-2025)
Table 5. Global Gene Therapy Revenue Share by Region (2020-2025)
Table 6. Global Gene Therapy Revenue (US$ Million) Forecast by Region (2026-2031)
Table 7. Global Gene Therapy Revenue Share Forecast by Region (2026-2031)
Table 8. Global Gene Therapy Market Size by Type (2020-2025) & (US$ Million)
Table 9. Global Gene Therapy Revenue Market Share by Type (2020-2025)
Table 10. Global Gene Therapy Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 11. Global Gene Therapy Revenue Market Share by Type (2026-2031)
Table 12. Representative Players of Each Type
Table 13. Global Gene Therapy Market Size by Application (2020-2025) & (US$ Million)
Table 14. Global Gene Therapy Revenue Market Share by Application (2020-2025)
Table 15. Global Gene Therapy Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 16. Global Gene Therapy Revenue Market Share by Application (2026-2031)
Table 17. New Sources of Growth in Gene Therapy Application
Table 18. Global Gene Therapy Revenue by Players (2020-2025) & (US$ Million)
Table 19. Global Gene Therapy Market Share by Players (2020-2025)
Table 20. Global Top Gene Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Therapy as of 2024)
Table 21. Ranking of Global Top Gene Therapy Companies by Revenue (US$ Million) in 2024
Table 22. Global 5 Largest Players Market Share by Gene Therapy Revenue (CR5 and HHI) & (2020-2025)
Table 23. Global Key Players of Gene Therapy, Headquarters and Area Served
Table 24. Global Key Players of Gene Therapy, Product and Application
Table 25. Global Key Players of Gene Therapy, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. North America Gene Therapy Revenue by Company (2020-2025) & (US$ Million)
Table 28. North America Gene Therapy Revenue Market Share by Company (2020-2025)
Table 29. North America Gene Therapy Market Size by Type (2020-2025) & (US$ Million)
Table 30. North America Gene Therapy Market Size by Application (2020-2025) & (US$ Million)
Table 31. Europe Gene Therapy Revenue by Company (2020-2025) & (US$ Million)
Table 32. Europe Gene Therapy Revenue Market Share by Company (2020-2025)
Table 33. Europe Gene Therapy Market Size by Type (2020-2025) & (US$ Million)
Table 34. Europe Gene Therapy Market Size by Application (2020-2025) & (US$ Million)
Table 35. China Gene Therapy Revenue by Company (2020-2025) & (US$ Million)
Table 36. China Gene Therapy Revenue Market Share by Company (2020-2025)
Table 37. China Gene Therapy Market Size by Type (2020-2025) & (US$ Million)
Table 38. China Gene Therapy Market Size by Application (2020-2025) & (US$ Million)
Table 39. Japan Gene Therapy Revenue by Company (2020-2025) & (US$ Million)
Table 40. Japan Gene Therapy Revenue Market Share by Company (2020-2025)
Table 41. Japan Gene Therapy Market Size by Type (2020-2025) & (US$ Million)
Table 42. Japan Gene Therapy Market Size by Application (2020-2025) & (US$ Million)
Table 43. Southeast Asia Gene Therapy Revenue by Company (2020-2025) & (US$ Million)
Table 44. Southeast Asia Gene Therapy Revenue Market Share by Company (2020-2025)
Table 45. Southeast Asia Gene Therapy Market Size by Type (2020-2025) & (US$ Million)
Table 46. Southeast Asia Gene Therapy Market Size by Application (2020-2025) & (US$ Million)
Table 47. India Gene Therapy Revenue by Company (2020-2025) & (US$ Million)
Table 48. India Gene Therapy Revenue Market Share by Company (2020-2025)
Table 49. India Gene Therapy Market Size by Type (2020-2025) & (US$ Million)
Table 50. India Gene Therapy Market Size by Application (2020-2025) & (US$ Million)
Table 51. Biogen Company Details
Table 52. Biogen Business Overview
Table 53. Biogen Gene Therapy Product
Table 54. Biogen Revenue in Gene Therapy Business (2020-2025) & (US$ Million)
Table 55. Biogen Recent Development
Table 56. Novartis Company Details
Table 57. Novartis Business Overview
Table 58. Novartis Gene Therapy Product
Table 59. Novartis Revenue in Gene Therapy Business (2020-2025) & (US$ Million)
Table 60. Novartis Recent Development
Table 61. Gilead Sciences Company Details
Table 62. Gilead Sciences Business Overview
Table 63. Gilead Sciences Gene Therapy Product
Table 64. Gilead Sciences Revenue in Gene Therapy Business (2020-2025) & (US$ Million)
Table 65. Gilead Sciences Recent Development
Table 66. Sarepta Therapeutics Company Details
Table 67. Sarepta Therapeutics Business Overview
Table 68. Sarepta Therapeutics Gene Therapy Product
Table 69. Sarepta Therapeutics Revenue in Gene Therapy Business (2020-2025) & (US$ Million)
Table 70. Sarepta Therapeutics Recent Development
Table 71. Alnylam Pharmaceuticals Company Details
Table 72. Alnylam Pharmaceuticals Business Overview
Table 73. Alnylam Pharmaceuticals Gene Therapy Product
Table 74. Alnylam Pharmaceuticals Revenue in Gene Therapy Business (2020-2025) & (US$ Million)
Table 75. Alnylam Pharmaceuticals Recent Development
Table 76. Amgen Company Details
Table 77. Amgen Business Overview
Table 78. Amgen Gene Therapy Product
Table 79. Amgen Revenue in Gene Therapy Business (2020-2025) & (US$ Million)
Table 80. Amgen Recent Development
Table 81. Spark Therapeutics Company Details
Table 82. Spark Therapeutics Business Overview
Table 83. Spark Therapeutics Gene Therapy Product
Table 84. Spark Therapeutics Revenue in Gene Therapy Business (2020-2025) & (US$ Million)
Table 85. Spark Therapeutics Recent Development
Table 86. Akcea Therapeutics Company Details
Table 87. Akcea Therapeutics Business Overview
Table 88. Akcea Therapeutics Gene Therapy Product
Table 89. Akcea Therapeutics Revenue in Gene Therapy Business (2020-2025) & (US$ Million)
Table 90. Akcea Therapeutics Recent Development
Table 91. bluebird bio Company Details
Table 92. bluebird bio Business Overview
Table 93. bluebird bio Gene Therapy Product
Table 94. bluebird bio Revenue in Gene Therapy Business (2020-2025) & (US$ Million)
Table 95. bluebird bio Recent Development
Table 96. Sunway Biotech Company Details
Table 97. Sunway Biotech Business Overview
Table 98. Sunway Biotech Gene Therapy Product
Table 99. Sunway Biotech Revenue in Gene Therapy Business (2020-2025) & (US$ Million)
Table 100. Sunway Biotech Recent Development
Table 101. SIBIONO Company Details
Table 102. SIBIONO Business Overview
Table 103. SIBIONO Gene Therapy Product
Table 104. SIBIONO Revenue in Gene Therapy Business (2020-2025) & (US$ Million)
Table 105. SIBIONO Recent Development
Table 106. AnGes Company Details
Table 107. AnGes Business Overview
Table 108. AnGes Gene Therapy Product
Table 109. AnGes Revenue in Gene Therapy Business (2020-2025) & (US$ Million)
Table 110. AnGes Recent Development
Table 111. Orchard Therapeutics Company Details
Table 112. Orchard Therapeutics Business Overview
Table 113. Orchard Therapeutics Gene Therapy Product
Table 114. Orchard Therapeutics Revenue in Gene Therapy Business (2020-2025) & (US$ Million)
Table 115. Orchard Therapeutics Recent Development
Table 116. Human Stem Cells Institute Company Details
Table 117. Human Stem Cells Institute Business Overview
Table 118. Human Stem Cells Institute Gene Therapy Product
Table 119. Human Stem Cells Institute Revenue in Gene Therapy Business (2020-2025) & (US$ Million)
Table 120. Human Stem Cells Institute Recent Development
Table 121. Gene Therapy Market Trends
Table 122. Gene Therapy Market Drivers
Table 123. Gene Therapy Market Challenges
Table 124. Gene Therapy Market Restraints
Table 125. Research Programs/Design for This Report
Table 126. Key Data Information from Secondary Sources
Table 127. Key Data Information from Primary Sources
List of Figures
Figure 1. Gene Therapy Product Picture
Figure 2. Global Gene Therapy Market Share by Type: 2024 VS 2031
Figure 3. Viral Gene Therapy Features
Figure 4. Non-Viral Gene Therapy Features
Figure 5. Global Gene Therapy Market Share by Application: 2024 VS 2031
Figure 6. Neurological Diseases
Figure 7. Cancer
Figure 8. Other
Figure 9. Gene Therapy Report Years Considered
Figure 10. Global Gene Therapy Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 11. Global Gene Therapy Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Gene Therapy Revenue Market Share by Region: 2020 VS 2024
Figure 13. North America Gene Therapy Revenue (US$ Million) Growth Rate (2020-2031)
Figure 14. Europe Gene Therapy Revenue (US$ Million) Growth Rate (2020-2031)
Figure 15. China Gene Therapy Revenue (US$ Million) Growth Rate (2020-2031)
Figure 16. Japan Gene Therapy Revenue (US$ Million) Growth Rate (2020-2031)
Figure 17. Southeast Asia Gene Therapy Revenue (US$ Million) Growth Rate (2020-2031)
Figure 18. India Gene Therapy Revenue (US$ Million) Growth Rate (2020-2031)
Figure 19. Middle East And Africa Gene Therapy Revenue (US$ Million) Growth Rate (2020-2031)
Figure 20. Global Gene Therapy Market Share by Players in 2024
Figure 21. Global Top Gene Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Therapy as of 2024)
Figure 22. The Top 10 and 5 Players Market Share by Gene Therapy Revenue in 2024
Figure 23. North America Gene Therapy Market Share by Type (2020-2025)
Figure 24. North America Gene Therapy Market Share by Application (2020-2025)
Figure 25. Europe Gene Therapy Market Share by Type (2020-2025)
Figure 26. Europe Gene Therapy Market Share by Application (2020-2025)
Figure 27. China Gene Therapy Market Share by Type (2020-2025)
Figure 28. China Gene Therapy Market Share by Application (2020-2025)
Figure 29. Japan Gene Therapy Market Share by Type (2020-2025)
Figure 30. Japan Gene Therapy Market Share by Application (2020-2025)
Figure 31. Southeast Asia Gene Therapy Market Share by Type (2020-2025)
Figure 32. Southeast Asia Gene Therapy Market Share by Application (2020-2025)
Figure 33. India Gene Therapy Market Share by Type (2020-2025)
Figure 34. India Gene Therapy Market Share by Application (2020-2025)
Figure 35. Biogen Revenue Growth Rate in Gene Therapy Business (2020-2025)
Figure 36. Novartis Revenue Growth Rate in Gene Therapy Business (2020-2025)
Figure 37. Gilead Sciences Revenue Growth Rate in Gene Therapy Business (2020-2025)
Figure 38. Sarepta Therapeutics Revenue Growth Rate in Gene Therapy Business (2020-2025)
Figure 39. Alnylam Pharmaceuticals Revenue Growth Rate in Gene Therapy Business (2020-2025)
Figure 40. Amgen Revenue Growth Rate in Gene Therapy Business (2020-2025)
Figure 41. Spark Therapeutics Revenue Growth Rate in Gene Therapy Business (2020-2025)
Figure 42. Akcea Therapeutics Revenue Growth Rate in Gene Therapy Business (2020-2025)
Figure 43. bluebird bio Revenue Growth Rate in Gene Therapy Business (2020-2025)
Figure 44. Sunway Biotech Revenue Growth Rate in Gene Therapy Business (2020-2025)
Figure 45. SIBIONO Revenue Growth Rate in Gene Therapy Business (2020-2025)
Figure 46. AnGes Revenue Growth Rate in Gene Therapy Business (2020-2025)
Figure 47. Orchard Therapeutics Revenue Growth Rate in Gene Therapy Business (2020-2025)
Figure 48. Human Stem Cells Institute Revenue Growth Rate in Gene Therapy Business (2020-2025)
Figure 49. Bottom-up and Top-down Approaches for This Report
Figure 50. Data Triangulation
Figure 51. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Oral Antianginal Drugs Market Outlook, In‑Depth Analysis & Forecast to 2031
Oct 21, 25
Global Polyester BCF Yarns Market Outlook, In‑Depth Analysis & Forecast to 2031
Oct 21, 25
Global Glass Mat Reinforced Thermoplastics (GMT) for Automotive Market Outlook, In‑Depth Analysis & Forecast to 2031
Oct 21, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232